Pharmabiz10h
Centre bans chloramphenicol and nitrofurans for use in food-producing animals
The Union health ministry has banned the import, manufacture, sale and distribution of antibiotic chloramphenicol and nitrofurans class of drugs for use in any food-producing animal rearing system ...
Pharmabiz10h
Centre reconstitutes DTAB
The new notification, issued on March 12 reconstitutes the 18 member committee which was constituted on October 18, 2021. The DTAB was reconstituted in May, 2018, prior to that. The revised board will ...
Pharmabiz10h
Focus on futuristic products, affordable solutions, says DoP secretary
Focus on futuristic products, affordable solutions, says DoP secretary: Our Bureau, New Delhi Thursday, March 13, 2025, 18:30 Hrs [IST] Focus on developing futuristic products and ...
Pharmabiz11h
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:50 Hrs [IST] Corona Remedies Limited ha ...
Pharmabiz11h
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies: Cambridge, Massachusetts Thursday, March 13, 2025, 18:00 Hrs [IST] Harbour BioMed, a gl ...
Pharmabiz11h
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant: Our Bureau, Mumbai Thursday, March 13, 2025, 17:40 Hrs [IST] In a significant development that c ...
Pharmabiz11h
Mankind Pharma launches affordable empagliflozin in India for diabetes
Mankind Pharma launches affordable empagliflozin in India for diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:30 Hrs [IST] Mankind Pharma has launched its affordable gen ...
Pharmabiz12h
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections: Petach Tikva, Israel Thursday, March 13, 2025 ...
Pharmabiz14h
QurAlis announces positive data from phase 1 trial of QRL-101 evaluating biomarkers of ALS and epilepsy in healthy volunteers
QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
Pharmabiz13h
Lipocine announces US FDA labelling changes for testosterone products
Lipocine announces US FDA labelling changes for testosterone products: Salt Lake City Thursday, March 13, 2025, 16:00 Hrs [IST] Lipocine Inc., a biopharmaceutical company leveragi ...
Pharmabiz18h
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...
Pharmabiz19h
Biogen begins TRANSCEND phase 3 study of felzartamab to treat late antibody-mediated rejection in kidney transplant patients
Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...